Julie A. Henry is an Enterprise IP Contract Manager in Department of Business Development, Mayo Clinic Ventures at Mayo Clinic in Rochester, Minnesota. Her responsibilities involve collaborating with internal and external customers as a resource to manage unique and complex intellectual property related contractual issues across the entire Mayo enterprise. Additionally, she is involved in the evaluation, patent strategy and out-licensing of a portfolio of Mayo Clinic inventions. Ms. Henry has been with Mayo Clinic for over twenty-five years. She has had experience in all facets of the commercialization process including drafting, negotiating and management of agreements. She has given presentations relating to licensing technologies as well as educating staff concerning intellectual property protection and commercialization. Before taking her position in Mayo Clinic Ventures, Ms. Henry was a Research Technician in the Peptide Synthesis Protein Sequencing Core Facility in Mayo Clinic’s Biochemistry and Molecular Biology Department. Ms. Henry received her B.A. from St. Cloud State University in St. Cloud, Minnesota and her Master of Business Administration from University of St. Thomas in Minneapolis, Minnesota.
Perry Hackett is a co-founder of Recombinetics and serves as Chair of its Scientific Advisory Board. He is co-founder of gene therapy company, Discovery Genomics, where he previously served as Chief Scientific Officer and Chairman. He is also a professor and research scientist in the University of Minnesota’s department of Genetics, Cell Biology and Development and co-founder of the Center for Genome Engineering. Hackett has a degree in Physics from Stanford University, a PhD in Biophysics and Genetics from the University of Colorado, and did postdoctoral training at the Max Planck Institute for Cell Biology in Germany and at the University of California in San Francisco.
Sara Russick has 20+ years in new-venture and emerging business success. Currently, she is Cofounder and General Partner of Capita3, a venture capital group focused on women-led companies innovating in health sectors. Sara is also Cofounder and Managing Director of Gopher Angels, an investing network. Gopher Angels is a leading funding source for Midwest early stage companies, with ~$14M invested into 42 Midwest companies. Gopher Angels has made significant investments in innovative health IT, life sciences, and medical devices companies. Previously, Sara cofounded and led 2 companies to exit. She cofounded Bagster, a nationwide waste and recycling company, where she served VP and Board Member prior to acquisition by a Fortune 500. Sara cofounded TUBS, Inc., a Midwest recycling company where she served as President. Sara serves on the Board of Directors for YWCA Minneapolis, is a member of Minnesota Women’s Economic Roundtable, and supports women as mentor and advisor. Sara is a graduate of the University of St Thomas.
Shaye Mandle has served as President & CEO of The Medical Alley Association since May 2014. Mr. Mandle has more than 20 years of experience in government, the private sector and academia, leading organizations, public affairs and political activities. From 2011-2014, Mr. Mandle served as the association’s EVP & COO and its VP of Government & Affiliate Relations. Prior to joining The Medical Alley Association, Mr. Mandle served as the Executive Director of the FedEx Institute of Technology at the University of Memphis, where he launched and oversaw the University Office of Technology Transfer and led the University’s corporate partnership, entrepreneurship and economic development programming. Mr. Mandle has served as the chief executive of two industry and economic development organizations, the Illinois Coalition for Science & Technology and the East-West Corporate Corridor Association.
J. Fernando Bazan was appointed Chief Technology Officer when he joined BioTechne on August 1, 2013. Following training at Stanford, Berkeley, and UCSF in biochemistry and biophysics, he led very active groups in biotherapeutics discovery as a senior scientist at DNAX Research Institute (now Merck Research Labs) and at Genentech (Roche). He also served as Chief Scientific Officer at NeuroScience, a neuroimmunology diagnostics startup. Dr. Bazan holds an adjunct faculty appointment in the Dept. of Pharmacology at the University of Minnesota School of Medicine.
Thomas J. Puff, Esq. is a nationally recognized corporate, securities law, mergers and acquisitions and venture capital attorney. He led the Securities Law Groups as a Partner in two large national law firms prior to founding Venture Law (VLR). VLR serves as our outside US Corporate Counsel and Mr. Puff is the Secretary to our Board. Mr. Puff has been involved in private placements, public offerings and debt and equity financings in domestic and international transactions aggregating over 650 million in his career, including service to issuers such as Michael Foods Inc., Taser Int’l, Stellent (acquired by Oracle), Health Fitness Corporation, Super Solutions (acquired by Oracle), ProUroCare, Metamodix, Redstone American Grill and investors St. Paul Venture Capital, Crescendo Ventures, The Pohlad Family Office/Sahara Investment Corp. along with dozens of prominent US angel investors/CEO’s such as John Goodman, Dr. Glen Nelson/GDN Holdings, Phil Smith, Founder Taser Int’l, John Morrison, Carl Pohlad, Irwin Jacobs, William Beddor and many others. He received his BA from Saint Olaf College (with Honors and Departmental Distinction) and his JD from The American University Law School in Washington, DC (with Honors).
Pamela York is a serial entrepreneur, early stage investor, and repeat inventor with a track record of success in several industries. Currently she the Co-founder and General Partner of CAPITA3, an early stage venture capital group focused on women-led companies in health sectors. Previously, Pam pioneered and successfully commercialized three technology platforms and co-founded two high tech startups with successful exits – Orchid Cellmark Inc. and Princeton Lightwave Inc. She also led the University of Iowa’s technology commercialization foundation, where she oversaw a portfolio of 1000 technologies concentrated in life sciences, built a startup ecosystem from scratch, and led the formation of 40 technology startups that raised over $150M in follow-on capital with 6 exits totaling $200M to date. She has a PhD in electrical engineering from the University of Illinois, holds numerous patents, and has authored many scientific publications. Pam is a commercial reviewer for the NSF SBIR program, the co-founder of the WEStart.MN movement for women entrepreneurs, a judge for the Minnesota Cup Food & Ag Division, and Board Chair for CoreBiome, a microbiome startup from the University of Minnesota. She is adjunct faculty at the University of Minnesota, teaching the NSF I-CorpsTM Value Proposition Design workshop and Business Formation.
Adam Choe joined the gener8tor team after 6 years of industry, and 2 years of academic research experience. Adam's industry experience included roles at companies such as Nestle Healthcare, WuXi AppTec and St. Jude Medical (now Abbott). Adam then transitioned to the University of Minnesota for back to back research fellowships (the first in Innovation and the second in Noninvasive Neuromodulation). Over the past 8 years, he has worked with new technologies in Medtech ranging from class III devices to software. Adam received his Bachelor of Science in Conservation Biology and Biology from the University of Wisconsin-Madison in 2010. He went on to receive his Master of Science in Medical Device Innovation from the University of Minnesota in 2016.
As Associate Director of the Holmes Center for Entrepreneurship and Program Director of MIN-Corps, Carla Pavone facilitates technology commercialization by designing and delivering education and coaching to University of Minnesota STEM students, faculty and researchers interested in bringing their innovations to the market. She also teaches entrepreneurship, strategy and leadership courses, primarily at the MBA level. Dr. Pavone has a BA in biology from University of Pennsylvania, an MBA from Harvard Business School, and a PhD in business administration from the Carlson School of Management. She has had three careers: in magazine and software publishing (primarily at start-ups), in financial services (mainly leading internal corporate start-ups and turnarounds) and in academia. She also currently serves on the boards of Social Venture Partners Minnesota and WomenVenture.